You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Argentina Patent: 072828


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 072828

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Apr 21, 2029 Alk Abello OTIPRIO ciprofloxacin
⤷  Start Trial Apr 27, 2030 Alk Abello OTIPRIO ciprofloxacin
⤷  Start Trial Apr 21, 2029 Alk Abello OTIPRIO ciprofloxacin
⤷  Start Trial Dec 11, 2029 Alk Abello OTIPRIO ciprofloxacin
⤷  Start Trial Apr 21, 2029 Alk Abello OTIPRIO ciprofloxacin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR072828

Last updated: August 5, 2025


Introduction

Patent AR072828 pertains to a pharmaceutical invention registered in Argentina, focusing on a specific drug or therapeutic formulation. This patent's scope and claims are fundamental in understanding its coverage, enforceability, and impact within the pharmaceutical patent landscape. This analysis dissects the patent's claims, elucidates its scope, and assesses its positioning within Argentina and the broader Latin American patent environment.


Patent Overview and Context

AR072828 was granted to secure exclusive rights over a novel pharmaceutical invention, which could encompass a broad spectrum of applications—from drug compositions and methods of manufacturing to inventive therapeutic use. While detailed technical disclosures are critical, the core patent claims define the boundaries of legal protection.

In Latin America, pharmaceutical patents must align with national patent laws, generally governed by the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). Argentina's patent law emphasizes the innovative step, novelty, and industrial applicability, with a careful examination of claims during patent prosecution.


Scope of Patent AR072828

The patent's scope hinges on its claims, which delineate what the patent covers. Broad claims afford extensive protection but face a higher risk of patent invalidation for lack of clarity or novelty, while narrow claims offer limited coverage but are easier to defend.

Primary Scope Features:

  • Therapeutic Agent Composition: If the patent claims a specific combination of active ingredients, it may prevent competitors from manufacturing or selling similar formulations within that scope, especially if the claims are comprehensive.
  • Method of Use or Administration: The patent might protect specific methods of administering the drug, such as particular dosage regimens or delivery technologies.
  • Manufacturing Process: The patent may encompass unique manufacturing steps or processes, securing process innovation.

The scope generally results from the independent claims—the broadest claim categories—and is further refined or limited by subsequent dependent claims.


Analysis of the Claims

While the actual patent document's precise claims are essential, typical claims in pharmaceutical patents like AR072828 can be categorized as follows:

1. Composition Claims

These claims describe specific drug formulations, comprising:

  • Active Ingredient(s): Including chemical compounds, biological agents, or a combination thereof.
  • Excipient(s): Substances aiding stability, bioavailability, or delivery.
  • Pharmaceutical Formulation: Such as tablets, injectables, topical preparations.

Scope: Composition claims aim to protect specific formulations that demonstrate improved efficacy, stability, or bioavailability.

2. Method of Manufacturing Claims

Claims covering innovative processes, such as:

  • Preparation Steps: Unique synthesis or purification methods.
  • Process Conditions: Specific temperatures, pH ranges, or catalysts.
  • Yield Optimization or Purity Improvements: Enhancements over prior art.

Scope: These are narrower but protect proprietary manufacturing techniques that can confer advantages and prevent competitors from copying.

3. Therapeutic Use or Method Claims

Claims asserting the use of the drug for treating particular diseases or conditions:

  • Method of Therapy: Administering a specific dose or formulation to treat a condition.
  • New Therapeutic Indications: Use of known drugs for new indications.

Scope: These claims are valuable when protecting off-label or innovative therapeutic applications.

4. Delivery and Administration Claims

Covering delivery devices, formulations optimized for certain routes, or specific administration protocols.


Patent Landscape in Argentina

Argentina's patent landscape reflects a mix of domestic innovation and foreign patent influence, with pharmaceutical patents being significantly scrutinized during prosecution for compliance with national law and TRIPS obligations.[1]

Key Features:

  • Patent Examination Focus: Argentina's Patent Office (INPI) emphasizes novelty, inventive step, and industrial applicability, often requiring detailed disclosures concerning modifications over prior art.
  • Pharmaceutical Patent Challenges: Argentina has historically adopted a cautious approach toward pharmaceutical patents, including law provisions aimed at balancing patent rights with access. Certain patents have faced opposition or invalidation based on lack of inventive step or insufficient disclosure.

Notable Patent Cases:

  • Several drug patents in Argentina have been challenged for lack of inventive step or non-compliance with disclosure requirements—areas that can impact AR072828’s enforceability.

Patent Term and Maintenance:

  • The standard patent term is 20 years from the filing date, with maintenance fees required at regular intervals to uphold rights.

Competitive Dynamics and Limitations

1. Patent Term and Generic Entry:

  • Once AR072828’s patent term expires, generic competitors can enter the market, subject to regulatory approval and patent challenges.

2. Compulsory Licensing and Public Interest:

  • Argentina law permits compulsory licensing in cases of public health emergencies, potentially limiting patent exclusivity for drugs deemed essential.

3. Parallel Patents in Latin America:

  • Given regional patent treaties and patent offices' cooperation, similar patents in neighboring countries influence Argentina's landscape.

4. Patentability Challenges:

  • Argentina has historically scrutinized pharmaceutical patent claims for inventive step, often requiring detailed disclosures and clear definitions.[2]

Implications for Stakeholders

  • Pharmaceutical Companies: Must craft claims carefully to maximize protection while ensuring patent validity under Argentine law.
  • Generic Manufacturers: Analyze claims and prosecution history to evaluate infringement risks or to design around the patent.
  • Legal and Regulatory Bodies: Oversight ensures balanced enforcement aligned with public health policies.

Key Takeaways

  • Claim Strategy: The strength and breadth of AR072828’s claims dictate its enforceability and market scope; focusing on specific compositions or methods enhances enforceability.
  • Patent Validity: Argentine patent law requires well-structured, clear claims with demonstrable inventive step, especially in pharmaceuticals.
  • Landscape Dynamics: The patent’s protective scope is influenced by regional patent policies, opposition trends, and public health provisions.
  • Market Impact: The patent's enforceability determines exclusivity duration, with expiration opening opportunities for generics.
  • Legal Risks: Non-compliance with patentability requirements or prior art references can diminish protection; proactive legal review is critical.

FAQs

1. What are the typical claim types in pharmaceutical patents like AR072828?
Claims generally include composition claims, method of manufacture, therapeutic use, and delivery methods, tailored to protect specific formulations, processes, and therapeutic applications.

2. How does Argentine patent law influence the scope of pharmaceutical patents?
Argentina emphasizes inventive step, clarity, and industrial applicability. Claims must demonstrate novelty and inventive contribution, affecting how broad or narrow the patent scope can be.

3. Can competitors challenge AR072828’s claims post-grant?
Yes, through opposition procedures or patent invalidation processes initiated during or after grant, especially if claims are deemed overly broad or unsupported.

4. How does regional patent law affect the patent landscape for AR072828?
Regional treaties and harmonization influence patent rights across Latin America; however, each country applies its national standards during examination and enforcement.

5. What strategies can patent holders use to protect their pharmaceutical innovations in Argentina?
Clear, detailed claims combined with comprehensive disclosures, alongside monitoring potential challenges, optimize patent resilience and market exclusivity.


References

  1. Argentine Patent Law, Law No. 24,481.
  2. Ginarte, J., & Valerio, D. (2017). Patentability and Patent Litigation in Argentina: Trends and Challenges. Latin American Intellectual Property Review.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.